Pfizer explores sale of hospital drugs unit
FDA declines full approval for Intercept's liver disease drug
AstraZeneca lifts 2024 forecast on better than expected Q3 performance
Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*
FDA declines full approval for Intercept's liver disease drug
AstraZeneca lifts 2024 forecast on better than expected Q3 performance
Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud *please scroll down for all the latest news*